Robert J. Schena, CEO of RHI, added: “This partnership reflects a fundamental shift from infrastructure that connects systems to platforms that operationalize intelligence. With Cowbell, RHI provides ...
Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities From research goal to lab-ready sequences in hours: Latent-Y compresses weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results